![](https://www.lachmanconsultants.com/wp-content/uploads/2024/01/iStock-1400948628.jpg)
New End of FY 2023 Posting by OGD Takes Some Time to Figure Out
The FDA published the Generic Drugs Program 2023 Fiscal Year Web Posting (here) on December 28, 2023. This document reflects the FDA’s performance for meeting GDUFA goal dates for FY 2023 submissions. The document meets the required reporting of certain performance metrics as outlined in the GDUFA III commitment letter. Bravo to the OGD for getting the report […]